Cargando…

Potentiation of TRAIL-Induced Apoptosis in TRAIL-Resistant Cholangiocarcinoma Cells by Curcumin through the Induction of DR5 Membrane Localization and Disruption of the Anti-Apoptotic Complex DR5/DDX3/GSK3β

OBJECTIVE: Cholangiocarcinoma (CCA) is a cancer of the bile duct with a poor prognosis. The present study examined the ability of curcumin to sensitize apoptosis in the TNF-related apoptosis-inducing ligand (TRAIL)-resistant CCA cell lines of HuCCA-1 and KKU-213A. METHODS: Apoptosis was measured usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Visitnonthachai, Daranee, Nakareangrit, Watanyoo, Suntararuks, Sumitra, Chaiyot, Kanjana, Watcharasit, Piyajit, Satayavivad, Jutamaad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162628/ https://www.ncbi.nlm.nih.gov/pubmed/36853289 http://dx.doi.org/10.31557/APJCP.2023.24.2.425

Ejemplares similares

Arsenic induces the global hypophosphorylation of insulin receptor substrate proteins in differentiated human neuroblastoma SH-SY5Y cells
por: Wisessaowapak, Churaibhon, et al.
Publicado: (2023)

Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y CELLS
por: Ngok-Ngam, Patchara, et al.
Publicado: (2012)

Acute oral toxicity evaluation of Andrographis paniculata-standardized first true leaf ethanolic extract
por: Worasuttayangkurn, Luksamee, et al.
Publicado: (2019)

Integrated Transcriptomics and Network Analysis of Potential Mechanisms and Health Effects of Convalescent COVID-19 Patients
por: Chujan, Suthipong, et al.
Publicado: (2023)

Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway
por: AMONYINGCHAROEN, SUMET, et al.
Publicado: (2015)

Anti‐cancer potentials of Gynura procumbens leaves extract against two canine mammary cancer cell lines
por: Jermnak, Usuma, et al.
Publicado: (2021)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
por: van Geelen, Caroline MM, et al.
Publicado: (2011)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

Dexamethasone Inhibits TRAIL-Induced Apoptosis through c-FLIP(L) Upregulation and DR5 Downregulation by GSK3β Activation in Cancer Cells
por: Jeon, Mi-Yeon, et al.
Publicado: (2020)

Activation of TRAIL‐DR5 pathway promotes sensorineural degeneration in the inner ear
por: Kao, Shyan‐Yuan, et al.
Publicado: (2016)

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
por: Kim, Jung Lim, et al.
Publicado: (2019)

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
por: Qiao, Chunxia, et al.
Publicado: (2012)

TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA
por: Han, Han, et al.
Publicado: (2017)

Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
por: Bychkov, Maxim L., et al.
Publicado: (2014)

Expression of TRAIL-R2 (DR5) on fibroblasts from synovial fluid of rheumatoid arthritis
por: Miranda, E, et al.
Publicado: (2004)

STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma
por: Simpson, Haley M., et al.
Publicado: (2018)

Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells
por: Shlyakhtina, Yelyzaveta, et al.
Publicado: (2017)

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020)

Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation
por: Hwang, Soon Young, et al.
Publicado: (2020)

Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2021)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021)

TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study
por: Loreto, C., et al.
Publicado: (2010)

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma
por: Yagolovich, Anne V., et al.
Publicado: (2022)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
por: Chen, Shuzhen, et al.
Publicado: (2010)

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2021)

Puma and Trail/Dr5 Pathways Control Radiation-Induced Apoptosis in Distinct Populations of Testicular Progenitors
por: Coureuil, Mathieu, et al.
Publicado: (2010)

Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms
por: Charette, N, et al.
Publicado: (2013)

TRAIL/DR5 Signaling Promotes Macrophage Foam Cell Formation by Modulating Scavenger Receptor Expression
por: Liu, Fang Fang, et al.
Publicado: (2014)

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients
por: Wu, Yanqiu, et al.
Publicado: (2015)

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
por: Zhou, Xinyu, et al.
Publicado: (2020)

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
por: Jeong, Dongjin, et al.
Publicado: (2021)

Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression
por: Ma, Liang, et al.
Publicado: (2022)

DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL
por: Marco-Brualla, Joaquín, et al.
Publicado: (2023)

TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ
por: Fossati, S, et al.
Publicado: (2012)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2022)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
por: Yagolovich, Anne V., et al.
Publicado: (2020)

Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
por: Ko, Hyeonseok, et al.
Publicado: (2015)

3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2018)

3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vic3ea9q7nmp1mqgdbc06cmfk8